Vera Therapeutics Inc (NASDAQ:VERA) price on Thursday, April 10, fall -0.95% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $21.81.
A look at the stock’s price movement, the close in the last trading session was $22.02, moving within a range at $20.34 and $22.4. The beta value (5-Year monthly) was 1.275. Turning to its 52-week performance, $51.61 and $18.53 were the 52-week high and 52-week low respectively. Overall, VERA moved -22.60% over the past month.
Vera Therapeutics Inc’s market cap currently stands at around $1.39 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-25.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VERA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 3 recommend VERA as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
VERA’s current price about -11.94% and -24.15% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.52, while 7-day volatility ratio is 13.78% and 7.62% in the 30-day chart. Further, Vera Therapeutics Inc (VERA) has a beta value of 1.30, and an average true range (ATR) of 2.09. Analysts have given the company’s stock an average 52-week price target of $34, forecast between a low of $6 and high of $38. Looking at the price targets, the low is 72.49% off current price level while to achieve the yearly target high, price needs to move -74.23%. Nonetheless, investors will most likely welcome a -55.89% jump to $34 which is the analysts’ median price.
If we refocus on Vera Therapeutics Inc (NASDAQ:VERA), historical trading data shows that trading volumes averaged 1.31 over the past 10 days and 954.43K over the past 3 months. The company’s latest data on shares outstanding shows there are 63.56 million shares.
The 23.22% of Vera Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 91.38% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.25 million on 2025-03-14, giving us a short ratio of 6.58. The data shows that as of 2025-03-14 short interest in Vera Therapeutics Inc (VERA) stood at 1514.0 of shares outstanding, with shares short falling to 8.36 million registered in 2025-02-14. Current price change has pushed the stock -48.43% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VERA stock continues to rise going into the next quarter.
